Review Article

National Consensus Guideline on Diagnosis and Management of Chronic Granulomatous Disease

Abstract

Currently, a national consensus or guideline for diagnosing and managing patients suspected of having chronic granulomatous disease (CGD) is lacking. This consensus is written based on a combination of scientific literature and comments from the expert panel of Iranian immunologists. A group of clinical immunologists reviewed the current consensus, presented their comments at a meeting titled “First Meeting on the Diagnosis of Inborn Errors of Immunity (IEI) by IEI Experts” and agreed on this consensus. This consensus guideline provides recommendations on the diagnosis, antimicrobial prophylaxis, management of clinical manifestations, administration of interferon gamma (IFN-γ) and hematopoietic stem cell transplantation (HSCT) for patients with CGD.

IssueVol 8, No 3 (2025) QRcode
SectionReview Article
 
Keywords
National Consensus Inborn Errors of Immunity Chronic Granulomatous Disease Management IFN-γ HSCT
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Delavari S, Yazdani R, Abolhassani H, Salami F, Ashournia P, Askarisarvestani A, Bahrami S, Behfar M, Bemanian MH, Cheraghi T, Darabi K, Darougar S, Ebrahimi S, Eskandarzadeh S, Eslamian G, Eslami N, Fallah S, Fallahpour M, Fekrvand S, Haghbin A, Hassanpoor Z, Hatefi Minaei H, Mesdaghi M, Mahdavi T, Marjani M, Mirazizi S, Modaresi M, Movahedi M, Nabavi M, Ranjbar M, Razaghian A, Saberi M, Sadeghi-Shabestari M, Sahragard M, Saleki K, Seraj S, Seyedsalehi S, Shafiei A, Sherkat R, Shiari R, Shokri S, Tavakoli S, Vosughimotlagh A, Rezaei N. National Consensus Guideline on Diagnosis and Management of Chronic Granulomatous Disease. Immunol Genet J. 2025;8(3).